ENLIVEX THERAPEUTICS LTD (ENLV)

IL0011319527 - Common Stock

1.5  -0.1 (-6.25%)

ENLIVEX THERAPEUTICS LTD

NASDAQ:ENLV (9/28/2023, 7:00:01 PM)

1.5

-0.1 (-6.25%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)07-31 2023-07-31/bmo
Earnings (Next)N/A N/A
Ins OwnersN/A
Inst Owners1.71%
Market Cap27.88M
Shares18.59M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.86
IPO07-30 2014-07-30
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ENLV Daily chart

Company Profile

Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

Company Info

ENLIVEX THERAPEUTICS LTD

14 Einstein St.

Ness Ziona 7403618

P: 97226708072.0

CEO: Oren Hershkovitz

Employees: 77

Website: https://www.enlivex.com/

ENLV News

News Image18 days ago - Enlivex Therapeutics LtdEnlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
News Image22 days ago - Enlivex Therapeutics LtdEnlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
News Image2 months ago - Enlivex Therapeutics LtdEnlivex Announces Peer-Reviewed Publication in Frontiers in Immunology of Clinical Data Details Resolution of Acute Respiratory Distress Syndrome (ARDS) from two Phase I/II Trials Evaluating Allocetra in Patients with COVID-19
News Image2 months ago - Enlivex Therapeutics LtdEnlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra™ In Patients With Sepsis
News Image2 months ago - Enlivex Therapeutics LtdEnlivex Announces Dosing of First Patient Under The Amended Protocol Of Its Phase II trial Evaluating Allocetra™ In Patients With Sepsis

Nes-Ziona, Israel, July 31, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming...

News Image3 months ago - Enlivex Therapeutics LtdEnlivex Announces First Quarter 2023 Financial Results and Provides a Business Update

ENLV Twits

Here you can normally see the latest stock twits on ENLV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example